Algorhythm Holdings receives Nasdaq minimum bid price deficiency notice
Algorhythm Holdings received notice on June 16, 2026 from Nasdaq that its common stock (RIME) failed to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days ending June 15, 2026. The company has until December 14, 2026 to regain compliance; if the closing bid price reaches at least $1.00 for ten consecutive business days during this 180-calendar-day period, Nasdaq will close the matter. The company may be eligible for an additional 180-calendar-day compliance period if it meets other listing standards and provides written notice of its intention to cure, potentially through a reverse stock split.
Key facts
- Minimum bid price requirement: $1.00 per share under Nasdaq Listing Rule 5550(a)(2)
- Initial compliance period: 180 calendar days, ending December 14, 2026
- Closing bid price measurement period: May 4, 2026 to June 15, 2026 (30 consecutive business days)
- Cure mechanism: closing bid price at least $1.00 for minimum of ten consecutive business days
- Potential secondary compliance period: additional 180 calendar days if company meets market value of publicly held shares and other initial listing standards
- Stock symbol: RIME on Nasdaq Capital Market
- No immediate trading suspension; stock continues trading during compliance period
Why it matters
Algorhythm Holdings has a six-month window to restore its stock price above the $1.00 minimum or face potential delisting from Nasdaq; failure to cure during the initial or any secondary compliance period could result in removal from the exchange.
Developing story
- NT 10-K
- 8-Kthis filing
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed 2026-06-18. Not investment advice. View the source filing on SEC.gov →